Estadísticas
Número total de visitas
| Visualizaciones | |
|---|---|
| Three-year outcomes in a randomized single-blind controlled trial of intravitreal ranibizumab and oral supplementation with docosahexaenoic Acid and antioxidants for diabetic macular edema | 173 |
Visitas al mes
| marzo 2024 | abril 2024 | mayo 2024 | junio 2024 | julio 2024 | agosto 2024 | septiembre 2024 | |
|---|---|---|---|---|---|---|---|
| Three-year outcomes in a randomized single-blind controlled trial of intravitreal ranibizumab and oral supplementation with docosahexaenoic Acid and antioxidants for diabetic macular edema | 4 | 8 | 24 | 14 | 18 | 40 | 39 |
Visitas al fichero
| Visualizaciones | |
|---|---|
| articulo7JL.pdf | 86 |
Países con más visualizaciones
| Visualizaciones | |
|---|---|
| Estados Unidos | 65 |
| Irlanda | 35 |
| Alemania | 24 |
| Reino Unido | 13 |
| Singapur | 13 |
| Suiza | 11 |
| España | 7 |
| Francia | 2 |
| India | 2 |
| Finlandia | 1 |
Ciudades con más visualizaciones
| Visualizaciones | |
|---|---|
| Dublin | 35 |
| Frankfurt am Main | 23 |
| London | 13 |
| Forest | 9 |
| El Monte | 6 |
| Yecla | 6 |
| Ashburn | 4 |
| Dallas | 3 |
| Navi Mumbai | 2 |
| Chicago | 1 |
